The largest database of trusted experimental protocols

13 protocols using anti cd68 antibody

1

TREM-1 Expression in Pulmonary TB

Check if the same lab product or an alternative is used in the 5 most similar protocols
To identify TREM-1-expressing inflammatory cells in lung tissues, we obtained lung specimens from two patients with pulmonary TB that were diagnosed based on pathologic characteristics and positive TB cultures of lung specimens. Both their lung specimens showed necrotizing granulomatous inflammation with the presence of mycobacterium, and the in-house TB polymerase chain reaction results were positive. IHC staining for TREM-1 expression analysis was carried out in the core facility of Taipei Veterans General Hospital. In short, 4-μm sections were prepared from formalin-fixed, paraffin-embedded tissues and the IHC staining was performed on a Leica Bond-MAX system (automatic IHC staining system). After deparaffinization, sections were pre-treated using heat-mediated antigen retrieval with sodium citrate buffer (pH 6, epitope retrieval solution 1) for 30 minutes. The section was then incubated with a human anti-TREM-1 antibody (ab93717, Abcam Inc.) at 10 µg/mL (diluted 1/100) for 60 minutes at room temperature, and detected using an HRP-conjugated compact polymer system (Anti-Rabbit IgG–Poly-HRP). The section was blocked with peroxide block (Bond Polymer Refine Detection, Leica Biosystems) for 5 minutes. DAB was used as the chromogen. IHC staining with anti-CD68 antibody (Dako, Glostrup, Denmark) was also performed to identify the presence of human macrophages in lung specimens.
+ Open protocol
+ Expand
2

Immunohistochemical Analysis of Mouse Tissues

Check if the same lab product or an alternative is used in the 5 most similar protocols
After sacrifice, mouse organs were fixed in 4% buffered formaldehyde for 24 h, rinsed with PBS, dehydrated in a series of graded ethanol and embedded in paraffin. Sections of 5 μm thickness were cut and stained with haematoxylin and eosin. For immunohistochemistry 5 μm thick sections were cut, dewaxed, microwaved in Target Retrieval Solution (DAKO) for 2 x 4 min and cooled down to room temperature for 40 min. After washing with Tris-buffered saline (TBS), non-specific binding was blocked by incubating sections in 10% normal swine serum (DAKO) for 30 min at room temperature. Slides were incubated with anti-CD68 antibody (ABCAM ab955) at a dilution of 1 μg/ml for 60 min (RT), followed by a biotinylated rabbit anti mouse antibody (DakoCytomation) at a dilution of 1:200 for 30 min. After careful washes in TBS, an incubation with an avidin-alkaline phosphatase complex (ABC kit, Vectastain, Vector) for 30 min followed and thereafter, additional washes in TBS were performed. Alkaline phosphatase activity was visualized using Liquid Permanent Red (LPR) Substrate-Chromogen (DAKO) for 15 min. After washing with water, slides were counterstained with Mayer's hemalum diluted 1:1 in water for ten seconds, blued under water and mounted with Eukitt® (Sigma).
+ Open protocol
+ Expand
3

Quantifying Tumor-Associated Immune Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Paraffin embedded tissues were analyzed using immunohistochemical staining [49 (link)] with the following primary antibodies: anti-CD68 antibody (DAKO, Carpinteria, CA), anti-α-SMA antibody (DAKO, Carpinteria, CA), anti-CCL7 antibody (Gen Way Biotech, San Diego, CA), anti-COL3A1 antibody (Bioss, Beijing, China), anti-FOXP3 antibody (Biolegend, San Diego, CA) and rabbit anti-Mouse CD68 antibody (Bioss, Beijing, China). For quantification of tumor stromal cells within the tumor area, CD68 was used as a pan-macrophage marker, α-SMA was used to detect cancer activated fibroblasts adjacent to RCC cells [50 (link)], FOXP3 was used as a specific marker for regulatory T cells (Tregs) [22 (link)], and mast cells were assessed using the routine toluidine blue staining method [21 (link)]. Each tumor section was evaluated by using 20× objective lens, and five independent areas with the most abundant positive cells were selected, digitally photographed, and manually counted under a microscope. The average positive cell counts for each patient were used for statistical analysis. For quantification of CD68+ cells in CDX xenografts, four sections from each xenograft were randomly selected and quantified as described above, the average positive cells for each mouse were used for statistical analysis. Results were confirmed by two pathologists in a double-blind analysis.
+ Open protocol
+ Expand
4

Evaluating Protein Expression and Macrophage Infiltration in CMT1A

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate CXCL1 and MCP-1 protein expression, de-identified sural nerve biopsies from two patients with genetically proven CMT1A (two women, ages 26 and 50) and two histologically normal samples from non-CMT1A patients (two women, ages 55 and 79) were obtained from the Johns Hopkins Neuromuscular Histopathology Laboratory under appropriate Institutional Review Board (IRB) supervision with informed consent. Lysates were obtained by sonicating nerve biopsies in RIPA buffer, and equal amounts of protein were then used for secreted protein expression profiling (R&D Systems, ARY005).
To evaluate the presence of CD68+ monocytes/macrophages, a diagnostic biopsy of the intercostal nerve was done in a 28 year old female patient with genetically confirmed CMT1A to evaluate for enlargement of her nerves and to rule out Schwannomatosis (under same IRB as above). She was diagnosed with CMT1A only a year prior to biopsy when she presented with pain and enlarged nerve roots and lumbosacral and brachial plexi. The biopsy showed classic features of an inherited demyelinating neuropathy with axonal loss and many mature onion bulbs. CD-68 immunostaining was performed in paraffin embedded sections with anti-CD68 antibody (DAKO cat # M071801–5) using standard immunohistochemical methods (Vectastain kit).
+ Open protocol
+ Expand
5

Evaluating Protein Expression and Macrophage Infiltration in CMT1A

Check if the same lab product or an alternative is used in the 5 most similar protocols
To evaluate CXCL1 and MCP-1 protein expression, de-identified sural nerve biopsies from two patients with genetically proven CMT1A (two women, ages 26 and 50) and two histologically normal samples from non-CMT1A patients (two women, ages 55 and 79) were obtained from the Johns Hopkins Neuromuscular Histopathology Laboratory under appropriate Institutional Review Board (IRB) supervision with informed consent. Lysates were obtained by sonicating nerve biopsies in RIPA buffer, and equal amounts of protein were then used for secreted protein expression profiling (R&D Systems, ARY005).
To evaluate the presence of CD68+ monocytes/macrophages, a diagnostic biopsy of the intercostal nerve was done in a 28 year old female patient with genetically confirmed CMT1A to evaluate for enlargement of her nerves and to rule out Schwannomatosis (under same IRB as above). She was diagnosed with CMT1A only a year prior to biopsy when she presented with pain and enlarged nerve roots and lumbosacral and brachial plexi. The biopsy showed classic features of an inherited demyelinating neuropathy with axonal loss and many mature onion bulbs. CD-68 immunostaining was performed in paraffin embedded sections with anti-CD68 antibody (DAKO cat # M071801–5) using standard immunohistochemical methods (Vectastain kit).
+ Open protocol
+ Expand
6

Immunohistochemical Analysis of Tissue Samples

Check if the same lab product or an alternative is used in the 5 most similar protocols
Tissue samples were fixed in 10% formalin and embedded in paraffin after fast decalcification (Decalcifier, Thermo shandon TBD1). Sections of 4–5 microns were made and stained with Haematoxylin Eosin for morphological study. Immunohistochemical studies were performed on histological sections from the same block, with the anti-CD 68 antibody (Dako), which recognizes the monocyte/macrophage (1/100, 30 min), anti CD-34 (Immunotech), which marks the vessels (1/100, 30 min) and anti CD 45 (Dako), which indicates leukocytes (1/100, 30 min). The revelation was made by the avidin–biotin-peroxidase technique (LSAB kit).
+ Open protocol
+ Expand
7

Isolation and Culture of Primary Human Nasal Epithelial Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
This study was approved by the Institutional Review Board for Clinical Research of Hokkaido University Hospital, Sapporo, Japan (019–0242) and by The Queen Elizabeth Hospital Human Research Ethics Committee (reference HREC/15/TQEH/132), and was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from study participants prior to tissue or cell collection. Primary human nasal epithelial cells (HNECs) were taken from the nasal mucosa of the inferior turbinates of seven patients treated for deviation of the nasal septum as previously described (Cooksley et al., 2015 (link); Suzuki et al., 2018 (link); Ramezanpour et al., 2019 (link)). The cells were suspended in Bronchial Epithelial Growth Medium (BEGM, CC-3170, Lonza, Walkersville, MD, USA) supplemented with Amphotericin B (Fujifilm, Osaka, Japan) and Penicillin/Streptomycin (Fujifilm, Osaka, Japan). Monocytes were depleted from the cell suspension using anti-CD68 antibody (Dako, Glostrup, Denmark) -coated cell culture dishes. HNECs were incubated at 37°C in humidified conditions under 5% CO2 in collagen-coated flasks (Thermo Scientific, Waltham, MA, USA) until passage 2.
+ Open protocol
+ Expand
8

Antibody-based Inhibition of HB-EGF

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant human HB-EGF and anti-HB-EGF antibodies were purchased from R&D Systems (Minneapolis, MN, USA). Gefitinib was purchased from Cayman Chemical (Ann Arbor, MI, USA). Anti-EGF receptor antibody (D38B1) and anti-phosphorylated EGF receptor (pEGFR) antibody (Tyr1068, D7A5) were purchased from Cell Signaling Technology (CST; Danvers, MA, USA). Anti-CD68 antibody was purchased from Dako (Glostrup, Denmark). Anti-CD163 antibody was purchased from Leica Biosystems (Newcastle, UK). PD98059, LY294002, and U-73122 were purchased from Calbiochem (San Diego, CA, USA).
+ Open protocol
+ Expand
9

Automated Immunohistochemistry for PD-L1, CD8, and CD68

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunohistochemical staining was performed using an automated staining system (XT iVIEW DAB v3 SP; Ventana, Oro Valley, AZ) with anti‐PD‐L1 (E1L3N; Cell Signaling Technology, Danvers, MA), anti‐CD8 antibody (already diluted, Nichirei Biosciences, Tokyo, Japan), and anti‐CD68 antibody (dilution: 1:100, Dako, Glostrup, Denmark). Three micrometers thick FFPE sections were deparaffinized, subjected to heat‐induced antigen retrieval (100ºC for 90 min), and stained with anti‐PD‐L1 antibody (1:200 dilution) for 32 min.
To confirm sensitivity, anti‐PD‐L1 antibody staining was validated using PD‐L1 IHC Controls (Cell Signaling Technology; Fig. 1A) and classical Hodgkin lymphomas (Fig. 1B),3, 11 which were embedded using standard procedures at Saitama Children's Medical Center.
+ Open protocol
+ Expand
10

Immunocytochemical Localization of P2Y12 and CD68

Check if the same lab product or an alternative is used in the 5 most similar protocols
Immunocytochemistry was performed using a rabbit polyclonal anti-P2Y12 antibody10 (link) (generated by Dr. H. Weiner, Harvard University, Cambridge, MA), a monoclonal anti-CD68 antibody (Dako, Burlington, Ontario, Canada; 1:100), and appropriate secondary antibodies. For human brain sections, slides were deparaffinized and antigen retrieval was performed using a 0.01 M sodium citrate buffer solution (pH 6.0) for 15 minutes in the microwave on high setting.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!